(Q44627507)

English

Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients

scientific article published on January 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

Jean-Pierre Després

3

object named as

Jean-Pierre Després

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Isabelle Lemieux

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hervé Salomon

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1080/07853890310011969

1 reference

10.1080/07853890310011969

https://api.crossref.org/works/10.1080/07853890310011969

24 March 2024

Annals of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

442-448

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Lipoprotein lipase: recent contributions from molecular biology

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women

1 reference

https://api.crossref.org/works/10.1080%2F07853890310011969

21 January 2018

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

1

1 reference

10.1080/07853890310011969

https://api.crossref.org/works/10.1080/07853890310011969

24 March 2024

Change in LDL particle size is associated with change in plasma triglyceride concentration

6

1 reference

10.1080/07853890310011969

https://api.crossref.org/works/10.1080/07853890310011969

24 March 2024

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

15

1 reference

10.1080/07853890310011969

https://api.crossref.org/works/10.1080/07853890310011969

24 March 2024

Identifiers

10.1080/07853890310011969

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44627507&oldid=2153251041"